INS and Glucose intolerance: However, most phytocannabinoids appear to have the capacity to not only impact the kidneys through the SGLT2 receptor by inhibiting glucosuria but also have the potential to impact insulin secretion and insulin sensitivity, lower glucose intolerance, increase energy expenditure, and more [30,31].